Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending November 10, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending November 10, 2024

by Jonathan Hodson-Walker | Nov 14, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions ZAP Surgical: The company raised $78 million of Series E venture funding in a deal led by Baheal Pharmaceutical Group on November 8, 2024. The company is an operator of a medical technology...
Healthcare Private Placement and M&A Transactions Review Week Ending November 3, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending November 3, 2024

by Jonathan Hodson-Walker | Nov 7, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Seaport Therapeutics: The company raised $226 million of Series B venture funding in a deal led by General Atlantic, ARCH Venture Partners, and Sofinnova Investments on October 31, 2024,...
Healthcare Private Placement and M&A Transactions Review Week Ending October 27, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending October 27, 2024

by Jonathan Hodson-Walker | Oct 31, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Seaport Therapeutics: The company raised $225 million of Series B venture funding in a deal led by General Atlantic, Arch Venture Partners, and Sofinnova Investments on October 21, 2024,...
Healthcare Private Placement and M&A Transactions Review Week Ending October 20, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending October 20, 2024

by Jonathan Hodson-Walker | Oct 24, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Terray Therapeutics: The company raised $120 million of Series B venture funding in a deal led by NVentures and Bedford Ridge Capital on October 17, 2024, putting the company’s...
Healthcare Private Placement and M&A Transactions Review Week Ending October 13, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending October 13, 2024

by Jonathan Hodson-Walker | Oct 17, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions City Therapeutics: The company raised $135 million of Series A venture funding in a deal led by ARCH Venture Partners on October 8, 2024. Regeneron Ventures, The Invus Group, AN Ventures,...
Healthcare Private Placement and M&A Transactions Review Week Ending October 6, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending October 6, 2024

by Jonathan Hodson-Walker | Oct 9, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Aktis Oncology: The company raised $175 million of Series B venture funding in a deal led by RA Capital Management, RTW Investments and Janus Henderson Investors on September 30, 2024. MRL...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives